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Background: The salivary flow rate is an important determinant of salivary pH. It is influenced by several metabolic
syndrome (MetS) components as well as the menopausal status. The cluster of cardiometabolic risk factors that
characterizes the MetS could be exacerbated following menopause. The objective of this study was therefore to
document the association between salivary pH and MetS expression in women according to the menopausal
status.
Methods: In this cross-sectional study, unstimulated saliva collection was performed on 198 Caucasian women of
French-Canadian origin of which 55 were premenopausal women (PMW) and 143 menopausal women (MW).
Student’s t test, ANOVA and correlation analyses were used to assess the association between salivary pH and MetS
components.
Results: The salivary pH level was significantly correlated with several MetS covariates, namely triglycerides (TG),
apolipoprotein B (apo B) and plasma glucose concentrations as well as waist circumference and the number of
MetS components present in the whole sample and PMW only. Mean pH levels decreased as the number of MetS
components increased (p = 0.004). The correlations between salivary pH and variables associated with MetS
components tended to be stronger in PMW. The proportion of the variance (R2) of salivary pH explained by MetS-
related variables in PMW, MW and the whole sample was 23.6% (p = 0.041), 18.1% and 17.0% (p < 0.001)
respectively.
Conclusions: The increasing prevalence of obesity calls for the development of new technologies to more easily
monitor health status without increasing the burden of healthcare costs. As such, the salivary pH could be an
inexpensive screening tool. These exploratory data suggest that salivary pH may be a significant correlate of the
expression of MetS components. However, other studies with different populations are needed to confirm these
findings before our observations lead to practical use in clinical settings.
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The metabolic syndrome (MetS) is a cluster of interre-
lated common clinical disorders, including obesity,
hyperglycemia, insulin resistance, dyslipidemia, increased
apolipoprotein B (apo B) levels, inflammation and hyper-
tension, associated with an increased risk of type 2 dia-
betes mellitus (T2DM) and cardiovascular disease
(CVD) [1]. MetS has received worldwide attention in the
past few years because of its prevalence, now ranging
from 20% to 30% of the adult population of almost all* Correspondence: daniel.gaudet@umontreal.ca
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reproduction in any medium, provided the orwestern countries, rising in parallel with that of obesity
[1]. It has also been shown that its prevalence increases
significantly during the perimenopausal and early post-
menopausal years, independently of known CVD risk
factors [2]. This may be a direct result of ovarian failure
or, alternatively, an indirect result of the metabolic con-
sequences of central fat redistribution with estrogen de-
ficiency [3]. In response to the increasing prevalence of
obesity and associated disorders coupled with the aging
of the western population, the MetS and the burden of
its consequences should become even more frequent in
the coming years. It thus becomes imperative to improve
the development of preventive and therapeutic strategiesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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T2DM and CVD. However, because of the insidious devel-
opment of the MetS, its early detection proves difficult. In-
deed, most people affected by it ignore their condition [1].
Consequently, the MetS is often diagnosed at a late stage
when signs and symptoms compel the affected person to
seek medical care [4,5]. This situation limits preventive
interventions and calls for new ways to carry out simple,
early assessments of MetS expression without increasing
the burden of healthcare costs. To meet this need, the
measurement of salivary pH, which is readily accessible
and inexpensive, could provide an interesting avenue.
The salivary flow rate is critical for the maintenance of
whole body health. Saliva helps bolus formation by
moistening food, protects the oral mucosa against mech-
anical damage, plays a role in preliminary digestion and
has defense functions against pathogen microorganism
[6]. The saliva flow rate is also a modulator of salivary
pH. At low flow rate, less bicarbonate is released, and
pH decreases [7]. The salivary flow rate varies widely be-
tween subjects [8,9]. Women have lower flow rates and
seem to have more variation in salivary pH than men.
Hormonal fluctuations during events like puberty, men-
struation, pregnancy and menopause could explain those
differences [10]. Salivary pH and flow rate are also
affected by various MetS components, such as obesity,
hypertriglyceridemia and hypertension [11-15]. More-
over, degenerative alterations in the acinar cells, which
cause a decrease of the saliva flow rate and a diminution
of salivary pH, are frequently observed among diabetic
and dyslipidemic patients [11,12].
The aim of this study was to examine the association
between salivary pH and MetS component expression in
women, taking into account their menopausal status.
Methods
Subjects and clinical data
The sample used in this study was composed of 198
Caucasian women of French-Canadian origin followed at
the Chicoutimi Hospital Lipid Clinic (Quebec, Canada).
Two groups were formed according to the menopausal
status: 55 premenopausal women (PMW) and 143 meno-
pausal women (MW). Menopausal status was attributed
to women who self-reported that their menses had
stopped for at least 12 months without surgery or had oc-
curred in the past 12 months but not in the last 3 months.
The menopausal status was also attributed when the hor-
monal cycle arrest was diagnosed by the physician or was
automatically attributed to all women of 50 years old or
older who had not confirmed that they still had menses at
the time of the interview. A dry mouth is more prevalent
in climacteric women than in premenopausal ones [16].
Considering that the hypothalamic-pituitary-ovarian axis
can affect saliva output and can be affected before awoman reaches menopausal status, the age limit of 50 was
chosen in order to include perimenopausal women [17].
Anthropometric variables were measured according to
validated procedures [18]. MetS components considered
were: abdominal obesity (waist circumference >88 cm),
high triglyceride (TG) level (> 1.7 mmol/L), low HDL-
cholesterol level (<1.3 mmol/L), elevated blood pressure
(≥130/85 mm Hg or diagnosed hypertension) and ele-
vated fasting glucose level (>5.6 mmol/L or diagnosed
T2DM) [1,19,20]. T2DM was defined according to the
World Health Organization criteria as a 2-h glucose
concentration ≥11.1 mmol/l following a 75 g oral glu-
cose load, whereas an impaired glucose tolerance (IGT)
state was characterized by a 2-h glucose concentration
between 7.8 and 11.1 mmol/L [21]. All hormonal drugs
were combined in a same unique covariate. The lipid-
lowering drugs were also grouped and processed as
user/non-user of medication. A written informed con-
sent was obtained for all participants, and all clinical
data were de-identified. The project was approved by the
Chicoutimi Hospital Ethics Committee, in accordance
with the Declaration of Helsinki.
Biochemical analyses
Blood samples were obtained after a 12-h overnight fast
into vacutainer tubes containing EDTA. The HDL subfrac-
tion was obtained after precipitation of LDL (d>1.006 g/ml)
in the infranatant with heparin and MnCl2 [22]. Cholesterol,
glucose and TG levels were measured by enzymatic essays
on a Multiparity Analyser CX7 (Beckman, Fullerton, CA,
USA) [23]. Plasma glycerol concentrations were measured
with an Technicon RA-500 analyzer (Bayer Corporation),
and enzymatic reagents were obtained from Randox (Ran-
dox Laboratories). Apo B levels were determined using
nephelometry.
Saliva collection and pH measurement
Although stimulated saliva is generally taken as the
index of salivary function, whole unstimulated saliva
collection was chosen for the purpose of this study be-
cause it is the greatest contributor to the total salivary
output [9,16,24]. All saliva samples were collected at
least 2 hours after any food intake or smoking, and the
same day as blood samples. Unstimulated saliva was
allowed to accumulate in the floor of the mouth, and the
subject then spat it out into a test tube during 10 min-
utes. The pH of the saliva sample was measured with
Accumet Basic AB 15 pH Meter (Ottawa, Canada), a 13-
620-96 Micro pH electrode, 1.5” stem (127 mm) x 3 mm
diameter with a pH range of 0 to 14 (Na + < 0.1 N) and
a selectable resolution to 0.1, 0.01 or 0.001pH. The mea-
surements were performed 3 times on each sample with
a 0.01 resolution. The final result was the mean value of
the measurements.
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Due to their skewed distribution, plasma TG, glycerol and
apo B values were log10-transformed before analyses. Geo-
metrical means are presented in Table 1. Differences in
continuous variables were compared by either the Stu-
dent’s t test or ANOVA. Categorical variables were com-
pared using the Pearson χ2 statistic or Fisher’s exact test.
Pearson’s correlations were performed to assess the rela-
tionship between MetS components and salivary pH. Fish-
er’s Z transformation was used to compare the correlation
coefficients. All-in-one models multivariate regression
analysis was constructed in order to investigate the rela-
tionship between salivary pH and covariates potentially
affecting its concentrations, namely: age, smoking habits,
waist girth, glycemia, TG and apo B levels. Use of medica-
tion as a covariate, including hormonal therapy and lipid-
lowering drugs, did not change the results in the different
models. All statistical analyses were performed with the
SPSS package (release 11.0, SPSS, Chicago III).
Results
Subjects’ characteristics are shown in Table 1. The differ-
ences in mean values between PMW and MW reached
the significance level (p < 0.05) for age, body mass index,
waist circumference, plasma glycerol and TG levels,Table 1 Subjects’ characteristics according to menopausal sta
Pre-menopausal women
(n=55)
Age (years) 47.7 ± 6.6
Range 24.0 - 52.0
BMI (kg/m2) 27.0 ± 4.8
Waist (cm) 88.26 ± 11.73
Salivary pH 6.64 ± 0.34
Glycemia (mmol/L) 5.68 ± 2.08
Glycerol (mmol/L) * 0.07 ± 0.06
CT (mmol/L) 5.79 ± 1.36
HDL-C (mmol/L) 1.35 ± 0.48
TG (mmol/L) * 1.36 ± 3.86
Apo B (g/L) *a 1.01 ± 0.28
Systolic blood pressure 120.0 ± 16.8
Diastolic blood pressure 74.1 ± 9.0
T2DM (%) 20.0
IGT or T2DM (%)b 29.1
Exogenous hormone
use (%) 0
Abbreviations BMI: body mass index; CT: cholesterol total; HDL-C: high-density lipo
Diabetes Mellitus; IGT: impaired glucose tolerance.
a : n for PMW =54 and n for MW=139.
b : n for PMW =34 and n for MW=74.
Mean ± SD. NS: p > 0.1.
*P-values were obtained after the log10-transpormation of the data, and geometricsystolic blood pressure as well as the proportion of sub-
jects under exogenous hormone therapy. In addition, the
percentage of glucose intolerance in MW was signifi-
cantly increased as compared to PMW (p <0.001): the
percentage of T2DM in MW showed a 50% non-
significant increase when compared to PMW.
As shown in Figure 1, mean pH values decreased as
the number of MetS components increased from 0 to ≥3
in the whole sample (p = 0.004), after adjusting for age
and smoking habits. The results remained significant
even when hormonal therapy was included as a covari-
able. The same trend was observed in both PMW and
MW (respectively p = 0.057 and 0.042). There was a sig-
nificant interaction effect between the number of MetS
components and the menopausal status on the salivary
pH (p = 0.001).
Significant correlations (Table 2) were noted between
salivary pH and various MetS components. Plasma glu-
cose, TG and apo B levels as well as the number of MetS
components were significantly correlated to salivary pH
in the whole sample and PMW, even after adjustment
for age. The correlation coefficient between apo B and
salivary pH was significantly higher among PMW as
compared to MW (p= 0.04). The correlation between
plasma glucose and salivary pH also tended to be highertus
Menopausal women p-
value(n=143)
63.9 ± 7.6 <0.001
39.0 - 82.0
28.7 ± 5.4 0.040
93.11 ± 15.49 0.037
6.70 ± 0.30 NS
5.76 ± 1.62 NS
0.10 ± 0.05 <0.001
6.05 ± 1.05 NS
1.41 ± 0.33 NS
1.68 ± 1.65 0.031
1.08 ± 0.21 NS
134.3 ± 18.1 <0.001




protein cholesterol; TG: triglycerides; Apo B: apolipoprotein B; T2DM: type 2.
means are shown.
Figure 1 Mean salivary pH according to the number of metabolic components taking into account the effect of age and smoking
habits in the whole sample as well as among groups of PMW and MW. The MetS elements considered are: abdominal obesity, dyslipidemia
(high TG and low HDL-C levels), hyperglycemia and hypertension.
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pH and waist circumference and the number of MetS
elements reached the significance level in the whole
group and MW when corrected for age. Finally, plasma
TG levels were significantly correlated to the salivary pH
among all groups of women, even when the results were
corrected for age.
As shown in Table 3, the proportions of variance of
salivary pH explained by age and MetS-related variables
were 23.6 (p = 0.041), 18.1 and 17.0 (p < 0.001) for the
PMW, MW and the whole sample, respectively. Al-
though R2 tended to be higher in the PMW group, the
difference was not statistically significant. With the ex-
ception of age, the only variables to have a significant ef-
fect in the multivariate model were TG in MW
(p= 0.032), and apo B in PMW (p= 0.021) and the whole
sample (p = 0.007). In the multivariate analysis, age
reached the significance level in MW and the whole
group, but not in PMW.
Discussion
In our study, we found a significant correlation be-
tween salivary pH and the expression of MetS compo-
nents expression among women. To the best of our
knowledge, this is the first study investigating the asso-
ciation between the MetS and salivary pH. Although
numerous studies have shown correlations between
serum and saliva levels for a wide range of components,
none has studied saliva from this simple perspective
[9,11,12,25-28].
The correlation between salivary pH and MetS compo-
nent expression remained significant even after the in-
clusion of age as a covariate but tended to be stronger
among PMW. This could be explained by the facts thataging is an important risk factor for the MetS and meno-
pause is often associated with additional metabolic
alterations [2,29,30]. Moreover, the role of hormones in
several metabolic processes suggests that the onset of
menopause may influence the relationship between saliv-
ary pH and MetS component expression. Estrogen defi-
ciency may notably influence salivary flow rates by
indirect pathways. Dyslipidemia, diabetes and hyperten-
sion have been related to a decrease of the salivary flow,
and their simultaneous presence could act as a con-
founding factor [9,16,24].
Menopause, as a risk factor for almost all components
of the MetS [31], may put a woman at risk of developing
salivary dysfunction. In addition, other disorders asso-
ciated with aging, including but not limited to obesity
[31], rheumatoid arthritis and fibromyalgia [32], depres-
sion [33] and nutritional deficiencies [34], could also re-
duce the salivary function. The associated permanent
histological changes in the salivary glands they can trig-
ger may also explain the differences we tended to ob-
serve between PMW and MW in the present study [35].
Among the different variables associated with the
MetS, TG is the most significantly related to salivary pH,
followed by apo B and glycemia. Our results are there-
fore consistent with those of previous studies that have
shown associations between salivary dysfunction and
high plasma lipid levels, particularly hypertriglyceridemia
and increased apo B concentrations [36-38]. However,
plasma levels of apo B and TG are not independently
related to salivary pH. Their relations with salivary pH
vary when other covariates are added to the models
(Table 3). Hypertriglyceridemia is part of a complex net-
work of interrelated metabolic abnormalities that act as
confounding factors when multivariate analyses are used
Table 2 Correlation between salivary pH and variables
associated with the metabolic syndrome
Age-adjusted
All women PMW MW All women PMW MW
n = 198 55 143 198 55 143
TG*
r -0.224 -0.300 -0.211 -0.294 -0.292 -0.289
p-value 0.001 0.026 0.011 <0.001 0.034 0.001
Apo B*
r -0.251 -0.458 -0.159 -0.293 -0.448 -0.149
p-value <0.001 <0.001 0.062 <0.001 0.001 0.082
Glycemia
r -0.163 -0.320 -0.081 -0.198 -0.304 -0.137
p-value 0.022 0.017 0.336 0. 006 0.027 0.112
Waist
r -0.142 -0.167 -0.159 -0.168 -0.166 -0.184
p-value 0.046 0.224 0.060 0.020 0.234 0.031
Systolic BP
r 0.047 -0.057 0.046 -0.052 0.023 -0.073
p-value 0.515 0.682 0.586 0.473 0.870 0.398
Diastolic BP
r -0.098 0.021 -0.140 -0.093 0.034 -0.122
p-value 0.173 0.880 0.096 0.201 0.809 0.156
HDL-C
r 0.091 0.048 0.110 0.089 0.075 0.149
p-value 0.201 0.728 0.191 0. 222 0.596 0. 083
MetS
r -0.171 -0.283 -0.144 -0.238 -0.261 -0.214
p-value 0.016 0.037 0.086 0.001 0.059 0.012
All correlation analyse are bivariate. TG: triglycerides; Apo B: apolipoprotein
B; PMW: premenopausal women; MW: menopausal women; HDL-C: high
density lipoprotein-cholesterol; MetS: number of metabolic syndrome
components. The MetS elements considered are: abdominal obesity,
dyslipidemia (high TG and low HDL-C levels), hyperglycemia and hypertension.
*Log10-transformed.
Table 3 All–in-one models multivariate regression
analyses of the relation between salivary pH and
metabolic syndrome elements
Salivary pH
PMW MW Whole Sample
R2 (%) 23.6 18.1 17.0
p-value 0.041 <0.001 <0.001
TG
B -0.117 -0.262 -0.167
Standard error 0.176 0.121 0.097
t -0.663 -2.164 -1.725
p-value 0.511 0.032 0.086
Apo B
B -1.207 -0.173 -0.658
Standard error 0.504 0.309 0.243
t -2.397 -0.559 -2.704
p-value 0.021 0.577 0.007
Glycemia
B -0.022 0.002 -0.013
Standard error 0.28 0.017 0.014
t -0.764 -0.104 -0.958
p-value 0.449 0.917 0.339
Waist
B 0.004 -0.002 -0.001
Standard error 0.005 0.002 0.002
t 0.730 -1.197 -0.896
p-value 0.469 0.234 0.371
Age
B 0.003 0.013 0.008
Standard error 0.007 0.003 0.002
t 0.455 4.059 3.839
p-value 0.651 <0.001 <0.001
Smoking habits
B -0.017 0.004 -0.014
Standard error 0.057 0.027 0.024
t -0.289 0.146 -0.594
p-value 0.774 0.884 0.553
TG: triglycerides; Apo B: apolipoprotein B; PMW: premenopausal women;
MW: menopausal women.
*Log10-transformed.
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the effect of hypertriglyceridemia in the multivariate
analysis. The significant result of apo B observed in MW
may be explained by a redistribution of body fat to the
abdominal region. Such a distribution is often associated
with both menopause and increased TG levels [40].
Many studies have found that the saliva flow rate and
pH are related to the level of glycemic control, particu-
larly in the presence of a severely impaired control of
blood glucose [41]. There is evidence that adverse hor-
monal, microvascular and neuronal changes in poorly
controlled diabetes could contribute to salivary gland
hypofunction [11,24,42-46]. The present study indicates
that differences in salivary pH could be linked withglucose control, particularly in PMW. In addition, stud-
ies have reported conflicting results on the relationship
between salivary pH and hypertension or hypertensive
therapy [24,47-49]. Our observations are therefore con-
sistent with those of studies that have found no differ-
ence between normal and hypertensive subjects. Finally,
considering that a BMI over 25 kg/m2 in adults and
obesity in childhood have been linked to hyposalivation
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in waist circumference frequently associated with a rise in
plasma TG and apo B concentrations. This is consistent
with the results of the univariate analysis, while no signifi-
cant effect of the waist circumference on the salivary pH
was observed in the multivariate models. The lack of sig-
nificant association between age and salivary pH among
PMW could be due to the combination of various factors
including the small size of the group, the smaller age-
range and the lower variability of the sample dispersion.
Our study has some limitations. Because of the cross-
sectional nature of the study, confounding factors such
as medication or permanent alterations in salivary glands
were not taken into consideration. Also, we didn’t have
information about the percentage on which subjects had
undergone a hysterectomy/bilateral oophorectomy or
where late perimenopausal. Moreover, this study does
not give any information about the potential causal path-
way affecting the salivary function. As an individual’s
flow rate and salivary pH remain relatively constant dur-
ing the different life stages, salivary gland hypofunction
is commonly associated with concomitant diseases and
daily use of drugs. Thus, a longitudinal study design with
disease or medication pre-test and post-test should be
more conclusive. Finally, our study should be replicated
in larger samples of women with various risk levels of
MetS components to obtain the real positive (PPV) and
negative predictive values (NPV) as well as specificity
and sensitivity values. However, despite its limitations,
our study emphasized the important association between
systemic and oral health. In the near future, further sci-
entific advances in salivary diagnosis could lead dentists
to be more involved in diagnosis and monitoring of
MetS components.
Conclusion
In the context of the increasing prevalence of obesity
and the MetS, efforts may need to be directed at the
identification of new, simple, non-invasive and inexpen-
sive screening tools to improve preventive strategies
without increasing the burden of healthcare costs. In
this pilot study, the salivary pH appeared as a possible
correlate of MetS component expression. However, fur-
ther studies are needed to confirm our findings. They
should include more subjects from various populations
in order to develop our observations into a definitive
methodology to monitor MetS components onset and
progression utilizing salivary pH.
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